LANZACLINIC MEDICO & ESTETICA SL
Company details
- Active NIF/CIF: B76182765
-
Telephone: Not available
-
Date of last BORME entry: 08/09/2020
-
Sector: Human Health and Social Work Activities
-
Address: Calle Dr. Gómez Ulla, 19, 35011 Las Palmas de Gran Canaria, Las Palmas, España See in map
-
Website: Not available
-
Featured products:
More information on LANZACLINIC MEDICO & ESTETICA SL
-
08/09/2020 | BORME act no.: 302513 | Register: LAS PALMASCeses/Dimisiones -
08/09/2020 | BORME act no.: 302513 | Register: LAS PALMASNombramientos
-
08/09/2020 | BORME act no.: 302513 | Register: LAS PALMASOtros conceptos
-
21/12/2015 | BORME act no.: 515677 | Register: LAS PALMASConstitución
-
21/12/2015 | BORME act no.: 515677 | Register: LAS PALMASNombramientos
Other information
The CIF assigned to LANZACLINIC MEDICO & ESTETICA SL is B76182765, and its business status is active. The company is engaged in an economic activity classified within the CNAE 8690 - Other health activities. In addition, its SIC identification - also defines it.
LANZACLINIC MEDICO & ESTETICA SL employs a team of Between 10 and 49 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Las palmas, and has 3 executive positions. Its most recent announcement in the Borme was published on 08/09/2020, while its last deposit of ordinary annual accounts is for the 2018 fiscal year.
To access the contact information of LANZACLINIC MEDICO & ESTETICA SL, such as the telephone number, postal address, or website, visit the Company Data module.
If you require more details about LANZACLINIC MEDICO & ESTETICA SL, we invite you to consult one of our available financial reports, the company's Annual Accounts, or to check its payment incidents in the RAI delinquency file.
The financial, business, and legal information provided about LANZACLINIC MEDICO & ESTETICA SL is extracted from official sources and is updated daily.
Do you want to know more about LANZACLINIC MEDICO & ESTETICA SL??
Find out more about this company by consulting these reports:
